Kindblom LG, Remotti HE, Aldenberg F,
Meis-Kindb1om JM. Gastrointestinal pacemaker cell tumors (GIPACT): gastrointestinal
stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J
Path 1998; 152:1259-1269.
Stemberg SS, Antonioli DA, Carter D,
Mills SE and Oberman HA, Diagnostic surgical pathology. 3rd edition 1999; Vol 2:pp 1337 -
1339 & 1454-1457.
Mazur MT, Clark HB: Gastric Stromal
Tumors. Deppraisal of Histogenesis. Am J. Surg Pathol 1983; 7: 507-519.
Rosai J. Ackerman's surgical pathology.
8th edition 1996; Vol 1: pp 1645-647
Lewin KD, Appleman HD. Tumors of the
esophagus and stomach. Atlas of tumor pathology, 3rd. Series, Fascicle 8. Washington D.C.:
AFIP 1996. pp 405-435
Hillemanns M. Pasold S. Bottcher K.
Hofler H. Pronostic factors of gastrointestinal stromal tumors of the stomach. Verh Disch
Ges Pathol 1998:
82:261 - 6.
Yoo J, Lee HK, Kang CS, Park WA, Lee
JY. Shim SI. P 53 gene mutations and p 53 protein expression in human soft tissue sarcoma.
Arch Pathol Lab Med 1997; 121:395-9.
Rubin BP, Fletcher JA, Fletcher Cd
Molecular insights into the histogenesis and pathologenesis of gastrointestinal stromal
tumors. Int J Surg pathol 2000;8:5-10.
Xiaojuan W.etal . Hospful parameters
for Malignant Potential of Gastrointestinal Stromal Tumors (GIST). Jpn J. Clin Oncol 2002;
32 (9) 47-351.
El Rifai W, Sarcomo RM, Andersson LC,
Mieffinem M, Knuntia S. DNA copy number changes in gastrointestinal stromal tumors - a
distinct genetic entity. Amm chir Gynalcol 1998, 87: 287-290.
El Rifai W, Sarlomo Rm, Miettinem M,
Knucetia S, Andersson LC. DNA copy number losses inchrosmoseme 14: and early change in
gastrointestinal stromal tumors. 1993 Cancer Res 56: 3230-3233.
Hirota S, Isozaki K. Moriyama Y.
Hashimoto K, Nishita T. Ishiguro S, et al. Gain - of- function mutations of c- kit in
human gastrointestinal stromal tumors. Science 1998;279: 577-80.
Tazawa K. Tsukada K. Makuuchi H.
Tsutsumi Y. An immunohistochemical and clinicopathological study of gastrointestinal
stromal tumors. Pathol int 1999; 49: 786 - 98.
Wang X-J, Tang W-H, Yu P-L. Su X - P,
Li S- Y, Histological and immunohistochemical study and AgNOR analysis of smooth muscle
tumors of the digestive tract. Zhong Hua Zhong Liu Za Zhi 1994;3 (16): 128 - 31.
Chang MS, Choe G, Kim WH, Kim YI. Small
intestinal stromal tumors: a clinicophatology study of 31 tumos. Pathol Int 1998; 48: 341
- 7.
Emory TS. Sobin LH, Lukes L, Lee DH,
O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors. An J Surg Pathol
1999;23:82 - 7.
Miettinen M, Sarlomo - Rikala M, Lasota
J. Gastrointestinal stromal tumors: recent advances in understanding of their bioloby. Um
Pathol 1999;30:1213 - 20.
Amin MB, Ma CK, Linden MD, Kubus JJ,
Zarbo RJ. Prognostic value of proliferating el nuclearantigen index in gastric stromal
tumors. Am J Clinic Phatol 1993; 100:428 - 32.
Demarchi LM. Reis MM, Palomino SA,
Garhat C. Takagaki TY, Beyruti R, et al. Prononostic values of stromal proportion and
PCNA, Ki -67 and p 53 proteins in patients with resected adenocarcinoma of the lung. Mod
Pathol 2000; 13:511-20.
Van de Rijn M, Hendrickson MR, Rouse
RV: The CD34 expression in by gastrointestinal stromal Hum Path 1994;25: 766 - 771.